94
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Exploring Patient’s Perspectives and Experiences After Start with Inhalation Maintenance Therapy: A Qualitative Theory-Based Study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 203-212 | Published online: 29 Jan 2020

References

  • Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290(17):2301–2312. doi:10.1001/jama.290.17.2301
  • Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). Available from: http://www.ginasthma.org. Archived by WebCite® at http://www.webcitation.org/75oQTDICX. Accessed January 30, 2019.
  • Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091
  • George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325–1334. doi:10.2147/PPA.S209532
  • Hesso I, Gebara SN, Kayyali R. Impact of community pharmacists in COPD management: inhalation technique and medication adherence. Respir Med. 2016;118:22–30. doi:10.1016/j.rmed.2016.07.010
  • Garcia-Cardenas V, Sabater-Hernandez D, Kenny P, Martinez-Martinez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107(9):1346–1355. doi:10.1016/j.rmed.2013.05.014
  • Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med. 2010;104(9):1237–1245. doi:10.1016/j.rmed.2010.04.012
  • Mannan H, Foo SW, Cochrane B. Does device matter for inhaled therapies in advanced chronic obstructive pulmonary disease (COPD)? A comparative trial of two devices. BMC Res Notes. 2019;12(1):94. doi:10.1186/s13104-019-4123-5
  • Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol. 2007;119(4):811–816. doi:10.1016/j.jaci.2006.11.700
  • Burgess SW, Sly PD, Devadason SG. Providing feedback on adherence increases use of preventive medication by asthmatic children. J Asthma. 2010;47(2):198–201. doi:10.3109/02770900903483840
  • Foster JM, Usherwood T, Smith L, et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol. 2014;134(6):1260–1268.e1263. doi:10.1016/j.jaci.2014.05.041
  • Gonzalez-Martin G, Joo I, Sanchez I. Evaluation of the impact of a pharmaceutical care program in children with asthma. Patient Educ Couns. 2003;49(1):13–18. doi:10.1016/S0738-3991(02)00027-7
  • Basheti IA, Qunaibi EA, Hamadi SA, Reddel HK. Inhaler technique training and health-care professionals: effective long-term solution for a current problem. Respir Care. 2014;59(11):1716–1725. doi:10.4187/respcare.02671
  • Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756–766. doi:10.1111/bcp.2014.77.issue-5
  • Price D, Bosnic-Anticevich S, Briggs A, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107(1):37–46. doi:10.1016/j.rmed.2012.09.017
  • Shanmugam S, Varughese J, Nair MA, et al. Pharmaceutical care for asthma patients: a developing country’s experience. J Res Pharm Pract. 2012;1(2):66–71. doi:10.4103/2279-042X.108373
  • Ganguli A, Clewell J, Shillington AC. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient Prefer Adherence. 2016;10:711–725. doi:10.2147/PPA.S101175
  • Narhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Educ Couns. 2001;43(2):171–177. doi:10.1016/S0738-3991(00)00158-0
  • Hammerlein A, Muller U, Schulz M. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2011;17(1):61–70. doi:10.1111/j.1365-2753.2010.01369.x
  • Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010;47(3):251–256. doi:10.3109/02770900903580843
  • Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med. 1997;45(2):189–201. doi:10.1016/S0277-9536(96)00333-4
  • Lycett H, Wildman E, Raebel EM, Sherlock JP, Kenny T, Chan AHY. Treatment perceptions in patients with asthma: synthesis of factors influencing adherence. Respir Med. 2018;141:180–189. doi:10.1016/j.rmed.2018.06.032
  • Gilworth G, Harries T, Corrigan C, Thomas M, White P. Perceptions of COPD patients of the proposed withdrawal of inhaled corticosteroids prescribed outside guidelines: a qualitative study. Chron Respir Dis. 2019;16:1479973119855880. doi:10.1177/1479973119855880
  • Rand CS. Patient adherence with COPD therapy. Eur Respir Rev. 2005;14(96):97–101. doi:10.1183/09059180.05.00009604
  • Koehorst-Ter Huurne K, Brusse-Keizer M, van der Valk P, Movig K, van der Palen J, Bode C. Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication. Patient Prefer Adherence. 2018;12:1777–1783. doi:10.2147/PPA.S167002
  • Atkins L, Francis J, Islam R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implementation Sci. 2017;12(1):77. doi:10.1186/s13012-017-0605-9
  • Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implementation Sci. 2012;7:37. doi:10.1186/1748-5908-7-37
  • Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26–33. doi:10.1136/qshc.2004.011155
  • French SD, Green SE, O’Connor DA, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implementation Sci. 2012;7:38. doi:10.1186/1748-5908-7-38
  • Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–175. doi:10.1136/qshc.2003.005926
  • Feifer RA, Greenberg L, Rosenberg-Brandl S, Franzblau-Isaac E. Pharmacist counseling at the start of therapy: patient receptivity to offers of in-person and subsequent telephonic clinical support. Popul Health Manag. 2010;13(4):189–193. doi:10.1089/pop.2009.0064
  • Hugtenburg JG, Blom AT, Gopie CT, Beckeringh JJ. Communicating with patients the second time they present their prescription at the pharmacy. Discovering patients’ drug-related problems. Pharm World Sci. 2004;26(6):328–332. doi:10.1007/s11096-004-0560-9
  • Hugtenburg JGB, Gopie CTW. Zinvolle actie aan de balie, Eerste en tweede uitgifte van geneesmiddelen. Pharm Weekbl. 2001;136(43):1612–1613.
  • Bond C, Matheson C, Williams S, Williams P, Donnan P. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract. 2000;50(453):271–275.
  • De Smet PA, Dautzenberg M. Repeat prescribing: scale, problems and quality management in ambulatory care patients. Drugs. 2004;64(16):1779–1800. doi:10.2165/00003495-200464160-00005
  • van Dijk L, Hendriks M, Zwikker H, de Jong J, Vervloet M Informatiebehoeften van patiënten over geneesmiddelen. Available from: https://www.nivel.nl/sites/default/files/bestanden/Informatiebehoeften_van_patienten_over_geneesmiddelen.pdf. Published 2016. Accessed January 4, 2019.
  • Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042
  • Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23. doi:10.1111/jcp.2008.33.issue-1
  • Wet op de geneeskundige behandelingsovereenkomst (WGBO). Available from: http://wetten.overheid.nl/BWBR0005290/2016-04-01#Boek7_Titel7_Afdeling5. Published 2018. Accessed September 21, 2018.
  • Koehler TC, Bok H, Westerman M, Jaarsma D. Developing a competency framework for pharmacy technicians: perspectives from the field. Res Social Adm Pharm. 2019;15(5):514–520.
  • KNMP. KNMP-richtlijn Ter hand stellen. Available from: https://www.knmp.nl/praktijkvoering/bekostiging/begeleidingsgesprek-nieuw-geneesmiddel/knmp-richtlijn-ter-hand-stellen/at_download/file_1. Published 2018. Accessed January 30, 2019..
  • World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC classifications system. Oslo: World Health Organization. Available from: https://www.whocc.no/atc_ddd_index/. Accessed June 11, 2018.
  • KNMP. KNMP-richtlijn COPD. Available from: https://www.knmp.nl/praktijkvoering/richtlijnen/knmp-richtlijnen-farmaceutische-zorg/knmp-richtlijn-copd. Published 2014. Accessed June 29, 2018.
  • Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res. 2017;27(4):591–608. doi:10.1177/1049732316665344
  • Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. doi:10.1177/1525822X05279903
  • Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol. 2014;7(5):633–644. doi:10.1586/17512433.2014.940896
  • Koster ES, van Meeteren MM, van Dijk M, et al. Patient-provider interaction during medication encounters: a study in outpatient pharmacies in the Netherlands. Patient Educ Couns. 2015;98(7):843–848. doi:10.1016/j.pec.2015.03.007
  • van Dijk M, Blom L, Koopman L, et al. Patient-provider communication about medication use at the community pharmacy counter. Int J Pharm Pract. 2016;24(1):13–21. doi:10.1111/ijpp.2016.24.issue-1
  • van Dulmen S. The value of tailored communication for person-centred outcomes. J Eval Clin Pract. 2011;17(2):381–383. doi:10.1111/jep.2011.17.issue-2
  • van Hulten R, Blom L, Mattheusens J, Wolters M, Bouvy M. Communication with patients who are dispensed a first prescription of chronic medication in the community pharmacy. Patient Educ Couns. 2011;83(3):417–422. doi:10.1016/j.pec.2011.05.020
  • Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–245. doi:10.1111/hex.2004.7.issue-3
  • Driesenaar JA, De Smet PA, van Hulten R, Hu L, van Dulmen S. Communication during counseling sessions about inhaled corticosteroids at the community pharmacy. Patient Prefer Adherence. 2016;10:2239–2254. doi:10.2147/PPA.S108006
  • Driesenaar JA, De Smet PA, van Hulten R, Noordman J, van Dulmen S. Cue-responding behaviors during pharmacy counseling sessions with patients with asthma about inhaled corticosteroids: potential relations with medication beliefs and self-reported adherence. Health Commun. 2016;31(10):1266–1275. doi:10.1080/10410236.2015.1062974